Bioengineering and Semisynthesis of an Optimized Cyclophilin Inhibitor for Treatment of Chronic Viral Infection
Magnus J. Hansson(Medicon Village), Matthew A. Gregory, Barrie Wilkinson(Norwich Research Park), Tony Warneck, Michael Bobardt(Scripps Research Institute), Mohammad Nur‐e‐Alam, Pieter Leyssen(Rega Institute for Medical Research), Nigel Coates(Isomerase Therapeutics (United Kingdom)), Steven J. Moss, Philippe Gallay(Scripps Research Institute), Jose A. Garcia-Rivera(Naval Medical Research Command), Eskil Elmér(Medicon Village), Johan Neyts(Rega Institute for Medical Research), Steve Kendrew, Udayan Chatterji(Scripps Research Institute)
Cited by 38
Related Papers
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
|Science|1996|4.9k
HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway
|Proceedings of the National Academy of Sciences|1997|483
HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase
|Cell|1995|355
Active Site Residues of Cyclophilin A Are Crucial for Its Signaling Activity via CD147
|Journal of Biological Chemistry|2002|338